Selectivity of δ- and κ-opioid ligands depends on the route of central administration in mice

Mary M. Lunzer, Philip S. Portoghese

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The existence of heterodimeric opioid receptors has introduced greater complexity to the in vivo characterization of pharmacological selectivity of agonists by antagonists. Because of the possibility of cooperativity between receptors organized as heterodimers, it is conceivable that selective antagonists may antagonize an agonist bound to a neighboring, allosterically coupled receptor. As a consequence, the in vivo selectivity of an opioid antagonist may depend on the organizational state of receptors that mediate analgesia. In this regard, phenotypic δ-and κ-opioid receptors have been proposed to arise from different organizational states that include oligomeric δ-κ heterodimers and homomeric δ and κ receptors. In view of the evidence for analgesia mediated by δ-κ heterodimers in the spinal cord, but not the brain, we have investigated the selectivity of pharmacologically selective δ and κ antagonists in mice by both i.t. and i.c.v. routes of administration to evaluate changes in selectivity. Using pharmacologically selective δ (benzylidenenaltrexone, naltrindole, and naltriben) and κ (norbinaltorphimine) antagonists versus δ ([D-Pen2,D-Pen5]-enkephalin and deltorphin II) and κ [3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]- benzeneacetamide (U50488) and bremazocine] agonists, the δ-1/δ-2 selectivity ratios were found to be dependent on the route of administration (i.t. versus i.c.v.). The data from different routes of administration suggest that differences in molecular recognition between spinal δ-κ heterodimers and supraspinal homomeric δ and κ receptors may contribute to the divergent selectivity ratios of selective antagonists. In view of the observed tissue-dependent selectivity, we suggest that multiple opioid antagonists be employed routinely in establishing agonist selectivity in vivo.

Original languageEnglish (US)
Pages (from-to)166-171
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume322
Issue number1
DOIs
StatePublished - Jul 1 2007

Fingerprint

naltrindole
Narcotic Antagonists
Opioid Receptors
Analgesia
Opioid Analgesics
Benzeneacetamides
D-Penicillamine (2,5)-Enkephalin
Ligands
Spinal Cord
Pharmacology
Brain
bremazocine
norbinaltorphimine
naltrindole benzofuran
Ala(2)-deltorphin II

Cite this

Selectivity of δ- and κ-opioid ligands depends on the route of central administration in mice. / Lunzer, Mary M.; Portoghese, Philip S.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 322, No. 1, 01.07.2007, p. 166-171.

Research output: Contribution to journalArticle

@article{51912cb353554bc1bc342ea80f837202,
title = "Selectivity of δ- and κ-opioid ligands depends on the route of central administration in mice",
abstract = "The existence of heterodimeric opioid receptors has introduced greater complexity to the in vivo characterization of pharmacological selectivity of agonists by antagonists. Because of the possibility of cooperativity between receptors organized as heterodimers, it is conceivable that selective antagonists may antagonize an agonist bound to a neighboring, allosterically coupled receptor. As a consequence, the in vivo selectivity of an opioid antagonist may depend on the organizational state of receptors that mediate analgesia. In this regard, phenotypic δ-and κ-opioid receptors have been proposed to arise from different organizational states that include oligomeric δ-κ heterodimers and homomeric δ and κ receptors. In view of the evidence for analgesia mediated by δ-κ heterodimers in the spinal cord, but not the brain, we have investigated the selectivity of pharmacologically selective δ and κ antagonists in mice by both i.t. and i.c.v. routes of administration to evaluate changes in selectivity. Using pharmacologically selective δ (benzylidenenaltrexone, naltrindole, and naltriben) and κ (norbinaltorphimine) antagonists versus δ ([D-Pen2,D-Pen5]-enkephalin and deltorphin II) and κ [3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]- benzeneacetamide (U50488) and bremazocine] agonists, the δ-1/δ-2 selectivity ratios were found to be dependent on the route of administration (i.t. versus i.c.v.). The data from different routes of administration suggest that differences in molecular recognition between spinal δ-κ heterodimers and supraspinal homomeric δ and κ receptors may contribute to the divergent selectivity ratios of selective antagonists. In view of the observed tissue-dependent selectivity, we suggest that multiple opioid antagonists be employed routinely in establishing agonist selectivity in vivo.",
author = "Lunzer, {Mary M.} and Portoghese, {Philip S.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1124/jpet.107.120279",
language = "English (US)",
volume = "322",
pages = "166--171",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Selectivity of δ- and κ-opioid ligands depends on the route of central administration in mice

AU - Lunzer, Mary M.

AU - Portoghese, Philip S.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - The existence of heterodimeric opioid receptors has introduced greater complexity to the in vivo characterization of pharmacological selectivity of agonists by antagonists. Because of the possibility of cooperativity between receptors organized as heterodimers, it is conceivable that selective antagonists may antagonize an agonist bound to a neighboring, allosterically coupled receptor. As a consequence, the in vivo selectivity of an opioid antagonist may depend on the organizational state of receptors that mediate analgesia. In this regard, phenotypic δ-and κ-opioid receptors have been proposed to arise from different organizational states that include oligomeric δ-κ heterodimers and homomeric δ and κ receptors. In view of the evidence for analgesia mediated by δ-κ heterodimers in the spinal cord, but not the brain, we have investigated the selectivity of pharmacologically selective δ and κ antagonists in mice by both i.t. and i.c.v. routes of administration to evaluate changes in selectivity. Using pharmacologically selective δ (benzylidenenaltrexone, naltrindole, and naltriben) and κ (norbinaltorphimine) antagonists versus δ ([D-Pen2,D-Pen5]-enkephalin and deltorphin II) and κ [3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]- benzeneacetamide (U50488) and bremazocine] agonists, the δ-1/δ-2 selectivity ratios were found to be dependent on the route of administration (i.t. versus i.c.v.). The data from different routes of administration suggest that differences in molecular recognition between spinal δ-κ heterodimers and supraspinal homomeric δ and κ receptors may contribute to the divergent selectivity ratios of selective antagonists. In view of the observed tissue-dependent selectivity, we suggest that multiple opioid antagonists be employed routinely in establishing agonist selectivity in vivo.

AB - The existence of heterodimeric opioid receptors has introduced greater complexity to the in vivo characterization of pharmacological selectivity of agonists by antagonists. Because of the possibility of cooperativity between receptors organized as heterodimers, it is conceivable that selective antagonists may antagonize an agonist bound to a neighboring, allosterically coupled receptor. As a consequence, the in vivo selectivity of an opioid antagonist may depend on the organizational state of receptors that mediate analgesia. In this regard, phenotypic δ-and κ-opioid receptors have been proposed to arise from different organizational states that include oligomeric δ-κ heterodimers and homomeric δ and κ receptors. In view of the evidence for analgesia mediated by δ-κ heterodimers in the spinal cord, but not the brain, we have investigated the selectivity of pharmacologically selective δ and κ antagonists in mice by both i.t. and i.c.v. routes of administration to evaluate changes in selectivity. Using pharmacologically selective δ (benzylidenenaltrexone, naltrindole, and naltriben) and κ (norbinaltorphimine) antagonists versus δ ([D-Pen2,D-Pen5]-enkephalin and deltorphin II) and κ [3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]- benzeneacetamide (U50488) and bremazocine] agonists, the δ-1/δ-2 selectivity ratios were found to be dependent on the route of administration (i.t. versus i.c.v.). The data from different routes of administration suggest that differences in molecular recognition between spinal δ-κ heterodimers and supraspinal homomeric δ and κ receptors may contribute to the divergent selectivity ratios of selective antagonists. In view of the observed tissue-dependent selectivity, we suggest that multiple opioid antagonists be employed routinely in establishing agonist selectivity in vivo.

UR - http://www.scopus.com/inward/record.url?scp=34250775006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250775006&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.120279

DO - 10.1124/jpet.107.120279

M3 - Article

C2 - 17400888

AN - SCOPUS:34250775006

VL - 322

SP - 166

EP - 171

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -